Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy

Chemotherapy-induced nausea and vomiting (CINV) is presented in over 30% of cancer patients receiving highly/moderately emetogenic chemotherapy (HEC/MEC). The currently recommended antiemetic therapy is merely based on the emetogenic level of chemotherapy, regardless of patient's individual ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhihuang, Liang, Wenhua, Yang, Yunpeng, Keefe, Dorothy, Ma, Yuxiang, Zhao, Yuanyuan, Xue, Cong, Huang, Yan, Zhao, Hongyun, Chen, Likun, Chan, Alexandre, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718276/
https://www.ncbi.nlm.nih.gov/pubmed/26765450
http://dx.doi.org/10.1097/MD.0000000000002476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718276/
https://www.ncbi.nlm.nih.gov/pubmed/26765450
http://dx.doi.org/10.1097/MD.0000000000002476

Ejemplares similares